Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

114 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Recruiting

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

NCT06506084

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • SC Ematologia, ASST Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Divisione Ematologia ASST, Grande Ospedale Metropolitano Niguarda Milan, Lombardy, Italy
  • Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo Pavia, Lombardy, Italy
  • U.O. Ematologia, Ospedale di Circolo e Fondazione Macchi Varese Varese, Lombardy, Italy
View all 37 locations
View Trial Details
Recruiting

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

NCT07203768

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University Hospital Halle Halle, Germany
  • Hannover Medical School Hanover, Germany
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden, Germany
View all 24 locations
View Trial Details
Recruiting

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

NCT07429266

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Regis Clinical Research LLC. Miami, Florida, United States
  • Florida Clinical Trials Group Plantation, Florida, United States
  • Florida Clinical Trials Group Tamarac, Florida, United States
  • The Center for Cancer & Blood Disorders Bethesda, Maryland, United States
View Trial Details
Recruiting

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

NCT04116502

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
View all 47 locations
View Trial Details
Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • University of Michigan ( Site 6000) Ann Arbor, Michigan, United States
  • DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States
  • UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States
View all 21 locations
View Trial Details
Recruiting

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

NCT06093672

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emad Ibrahim, MD, Inc Redlands, California, United States
  • US Oncology Inc Englewood, Colorado, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
View all 90 locations
View Trial Details
Recruiting

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

NCT05198960

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +24 more
Locations
  • CHU d'Angers Angers, France
  • CH d'Annecy Annecy, France
  • CH d'Argenteuil Argenteuil, France
  • CH d'Avignon Avignon, France
View all 42 locations
View Trial Details

Related conditions